发明授权
- 专利标题: Pyridazine, pyrimidine and pyrazine ethyne compounds
- 专利标题(中): 哒嗪,嘧啶和吡嗪乙炔化合物
-
申请号: US11097047申请日: 2005-04-01
-
公开(公告)号: US07462619B2公开(公告)日: 2008-12-09
- 发明人: Nicholas D. Cosford , Jeffrey R. Roppe , Lida R. Tehrani , Nicholas D. Smith , Brian Stearns , Dehua Huang , Bowei Wang , Thomas J. Seiders
- 申请人: Nicholas D. Cosford , Jeffrey R. Roppe , Lida R. Tehrani , Nicholas D. Smith , Brian Stearns , Dehua Huang , Bowei Wang , Thomas J. Seiders
- 申请人地址: US NJ Rahway
- 专利权人: Merck & Co., Inc.
- 当前专利权人: Merck & Co., Inc.
- 当前专利权人地址: US NJ Rahway
- 代理商 J. Eric Thies; William Krovatin
- 主分类号: C07D401/12
- IPC分类号: C07D401/12 ; C07D239/30 ; A61K31/444
摘要:
In accordance with the present invention, there is provided a novel class of heterocyclic compounds. Compounds of the invention contain a substituted or unsubstituted six membered heterocyclic ring that includes at least two nitrogen atoms. The ring additionally includes four carbon atoms. The heterocyclic ring has at least one substituent located at a ring position adjacent to a ring nitrogen atom. This mandatory substituent of the ring includes a moiety (B), linked to the heterocyclic ring via a carbon-carbon triple bond. The mandatory substituent is positioned adjacent to the ring nitrogen atom. Invention compounds are capable of a wide variety of uses. For example heterocyclic compounds can act to modulate physiological processes by functioning as agonists and antagonists of receptors in the nervous system. Invention compounds may also act as insecticides, and as fungicides. Pharmaceutical compositions containing invention compounds also have wide utility.
公开/授权文献
- US20050245542A1 Pyridazine, pyrimidine and pyrazine ethyne compounds 公开/授权日:2005-11-03
信息查询